Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia

British Journal of Haematology

Volumn 167, Issue 3, 2014, Pages 434-436

  Dee, Cathleen Michelle A ^a   Cheuk, Daniel Ka Leung ^a   Ha, Shau Yin ^a   Chiang, Alan Kwok Shing ^a   Chan, Godfrey Chi Fung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Deferasirox; Iron overload; Renal tubular dysfunction; Serum electrolyte; thalassaemia

Indexed keywords

BETA 2 MICROGLOBULIN; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; BENZOIC ACID DERIVATIVE; IRON CHELATING AGENT; PYRIDONE DERIVATIVE; TRIAZOLE DERIVATIVE;

ADULT; BETA THALASSEMIA; CHILD; CLINICAL ARTICLE; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE DISTURBANCE; FANCONI RENOTUBULAR SYNDROME; FEMALE; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; INCIDENCE; IRON CHELATION; IRON THERAPY; KIDNEY TUBULE DISORDER; LETTER; MALE; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RECOMMENDED DRUG DOSE; RESPIRATORY ALKALOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; YOUNG ADULT; ADOLESCENT; ALKALOSIS; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; KIDNEY DISEASE; KIDNEY TUBULE; METABOLIC DISORDER; PATHOPHYSIOLOGY;

ADOLESCENT; ALKALOSIS; BENZOATES; BETA 2-MICROGLOBULIN; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; CHILD; CHILD, PRESCHOOL; DEFEROXAMINE; FANCONI SYNDROME; FEMALE; HUMANS; IRON CHELATING AGENTS; KIDNEY DISEASES; KIDNEY TUBULES; MALE; PYRIDONES; RETROSPECTIVE STUDIES; TRIAZOLES; WATER-ELECTROLYTE IMBALANCE; YOUNG ADULT;

EID: 84911997344     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13002     Document Type: Letter

References (7)

1. Arcara, K.M. (2012) Chapter 27 Blood Chemistries and Body Fluids. In: The Harriet Lane Handbook: A Manual for Pediatric House Officers (eds. by Tschudy, M.M. & Arcara, K.M.), pp. 639-650. Elsevier Mosby Inc., Philadelphia, PA.
2. Cappellini, M.D., Bejaoui, M., Agaoglu, L., Canatan, D., Capra, M., Cohen, A., Drelichman, G., Economou, M., Fattoum, S., Kattamis, A., Kilinc, Y., Perrotta, S., Piga, A., Porter, J.B., Griffel, L., Dong, V., Clark, J. & Aydinok, Y. (2011) Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood, 118, 884-893.
3. Delea, T.E., Edelsberg, J., Sofrygin, O., Thomas, S.K., Baladi, J.-F., Phatak, P.D. & Coates, T.D. (2007) Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion, 47, 1919-1929.
4. Grangé, S., Bertrand, D.M., Guerrot, D., Eas, F. & Godin, M. (2010) Acute renal failure and Fanconi syndrome due to deferasirox. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association, 25, 2376-2378.
5. Patel, S.S., Molnar, M.Z., Tayek, J.A., Ix, J.H., Noori, N., Benner, D., Heymsfield, S., Kopple, J.D., Kovesdy, C.P. & Kalantar-Zadeh, K. (2013) Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. Journal of Cachexia, Sarcopenia and Muscle, 4, 19-29.
6. Portman, R.J., Kissane, J.M. & Robson, A.M. (1986) Use of beta 2 microglobulin to diagnose tubulo-interstitial renal lesions in children. Kidney International, 30, 91-98.
7. Wei, H.-Y., Yang, C.-P., Cheng, C.-H. & Lo, F.-S. (2011) Fanconi syndrome in a patient with β-thalassemia major after using deferasirox for 27 months. Transfusion, 51, 949-954.